BFKB8488A



NAME OF DRUG : BFKB8488A

ALSO KNOWN AS : BFKB8488A

LABORATORY : Genentech-ROCHE

STATUS AND ADVANCEMENT

Type of drug : Anti-FGFR1 - KLB MAb

Clinical trials advancement : Preclinic

Estimated time to market : 134 months.

LABORATORY ABSTRACT ON THE DRUG

NOT PROVIDED

RECENT NEWS ON BFKB8488A

SOME PUBLICATIONS RELATED WITH BFKB8488A

SOME NASHBIOTECHS POINTS OF VIEW RELATED WITH BFKB8488A


WWW.NASHBIOTECHS.COM  -  Copyright G DIVRY 2015-2016  - Contact and TERMS OF USE